BENZO HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION

To provide a pharmaceutical composition for treating or preventing cancer related to PD-L1, septic fever or sepsis shock.SOLUTION: There is provided a pharmaceutical composition including benzoxazole derivative expressed by a formula (I), and the composition is preferably administered in combination...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CHANG CHIA-MING, WEI TSAI-YIN, LU YEN-TA, SHIH TZENGE-LIEN, LIU JEN-WEI
Format: Patent
Sprache:eng ; jpn
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CHANG CHIA-MING
WEI TSAI-YIN
LU YEN-TA
SHIH TZENGE-LIEN
LIU JEN-WEI
description To provide a pharmaceutical composition for treating or preventing cancer related to PD-L1, septic fever or sepsis shock.SOLUTION: There is provided a pharmaceutical composition including benzoxazole derivative expressed by a formula (I), and the composition is preferably administered in combination with other anticancer agent, or an immunity check point inhibitor such as an anti PD-L1 antibody, an anti PD-1 antibody, an anti CTLA-4 antibody.SELECTED DRAWING: Figure 3 【課題】PD−L1関連のがん、敗血症もしくは敗血症性ショックを治療又は予防するための医薬組成物の提供。【解決手段】式(I)で代表されるベンゾオキサゾール誘導体を含む医薬組成物。他の抗がん剤、又は、抗PD−L1抗体、抗PD−1抗体、抗CTLA−4抗体等の免疫チェックポイント阻害剤と組み合わせて投与されることが好ましい。【選択図】図3
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2021008502A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2021008502A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2021008502A3</originalsourceid><addsrcrecordid>eNrjZLBycvWL8lfwcA1xDfJ3jnT28XRWcPb3DfAP9XNRcATiAA_HIF9HZ9fQEE9nRx-IXLBniKe_Hw8Da1piTnEqL5TmZlBycw1x9tBNLciPTy0uSExOzUstifcKMDIwMjQwsDA1MHI0JkoRACJLKag</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BENZO HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION</title><source>esp@cenet</source><creator>CHANG CHIA-MING ; WEI TSAI-YIN ; LU YEN-TA ; SHIH TZENGE-LIEN ; LIU JEN-WEI</creator><creatorcontrib>CHANG CHIA-MING ; WEI TSAI-YIN ; LU YEN-TA ; SHIH TZENGE-LIEN ; LIU JEN-WEI</creatorcontrib><description>To provide a pharmaceutical composition for treating or preventing cancer related to PD-L1, septic fever or sepsis shock.SOLUTION: There is provided a pharmaceutical composition including benzoxazole derivative expressed by a formula (I), and the composition is preferably administered in combination with other anticancer agent, or an immunity check point inhibitor such as an anti PD-L1 antibody, an anti PD-1 antibody, an anti CTLA-4 antibody.SELECTED DRAWING: Figure 3 【課題】PD−L1関連のがん、敗血症もしくは敗血症性ショックを治療又は予防するための医薬組成物の提供。【解決手段】式(I)で代表されるベンゾオキサゾール誘導体を含む医薬組成物。他の抗がん剤、又は、抗PD−L1抗体、抗PD−1抗体、抗CTLA−4抗体等の免疫チェックポイント阻害剤と組み合わせて投与されることが好ましい。【選択図】図3</description><language>eng ; jpn</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210128&amp;DB=EPODOC&amp;CC=JP&amp;NR=2021008502A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20210128&amp;DB=EPODOC&amp;CC=JP&amp;NR=2021008502A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHANG CHIA-MING</creatorcontrib><creatorcontrib>WEI TSAI-YIN</creatorcontrib><creatorcontrib>LU YEN-TA</creatorcontrib><creatorcontrib>SHIH TZENGE-LIEN</creatorcontrib><creatorcontrib>LIU JEN-WEI</creatorcontrib><title>BENZO HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION</title><description>To provide a pharmaceutical composition for treating or preventing cancer related to PD-L1, septic fever or sepsis shock.SOLUTION: There is provided a pharmaceutical composition including benzoxazole derivative expressed by a formula (I), and the composition is preferably administered in combination with other anticancer agent, or an immunity check point inhibitor such as an anti PD-L1 antibody, an anti PD-1 antibody, an anti CTLA-4 antibody.SELECTED DRAWING: Figure 3 【課題】PD−L1関連のがん、敗血症もしくは敗血症性ショックを治療又は予防するための医薬組成物の提供。【解決手段】式(I)で代表されるベンゾオキサゾール誘導体を含む医薬組成物。他の抗がん剤、又は、抗PD−L1抗体、抗PD−1抗体、抗CTLA−4抗体等の免疫チェックポイント阻害剤と組み合わせて投与されることが好ましい。【選択図】図3</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBycvWL8lfwcA1xDfJ3jnT28XRWcPb3DfAP9XNRcATiAA_HIF9HZ9fQEE9nRx-IXLBniKe_Hw8Da1piTnEqL5TmZlBycw1x9tBNLciPTy0uSExOzUstifcKMDIwMjQwsDA1MHI0JkoRACJLKag</recordid><startdate>20210128</startdate><enddate>20210128</enddate><creator>CHANG CHIA-MING</creator><creator>WEI TSAI-YIN</creator><creator>LU YEN-TA</creator><creator>SHIH TZENGE-LIEN</creator><creator>LIU JEN-WEI</creator><scope>EVB</scope></search><sort><creationdate>20210128</creationdate><title>BENZO HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION</title><author>CHANG CHIA-MING ; WEI TSAI-YIN ; LU YEN-TA ; SHIH TZENGE-LIEN ; LIU JEN-WEI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2021008502A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; jpn</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CHANG CHIA-MING</creatorcontrib><creatorcontrib>WEI TSAI-YIN</creatorcontrib><creatorcontrib>LU YEN-TA</creatorcontrib><creatorcontrib>SHIH TZENGE-LIEN</creatorcontrib><creatorcontrib>LIU JEN-WEI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHANG CHIA-MING</au><au>WEI TSAI-YIN</au><au>LU YEN-TA</au><au>SHIH TZENGE-LIEN</au><au>LIU JEN-WEI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BENZO HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION</title><date>2021-01-28</date><risdate>2021</risdate><abstract>To provide a pharmaceutical composition for treating or preventing cancer related to PD-L1, septic fever or sepsis shock.SOLUTION: There is provided a pharmaceutical composition including benzoxazole derivative expressed by a formula (I), and the composition is preferably administered in combination with other anticancer agent, or an immunity check point inhibitor such as an anti PD-L1 antibody, an anti PD-1 antibody, an anti CTLA-4 antibody.SELECTED DRAWING: Figure 3 【課題】PD−L1関連のがん、敗血症もしくは敗血症性ショックを治療又は予防するための医薬組成物の提供。【解決手段】式(I)で代表されるベンゾオキサゾール誘導体を含む医薬組成物。他の抗がん剤、又は、抗PD−L1抗体、抗PD−1抗体、抗CTLA−4抗体等の免疫チェックポイント阻害剤と組み合わせて投与されることが好ましい。【選択図】図3</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; jpn
recordid cdi_epo_espacenet_JP2021008502A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title BENZO HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T16%3A13%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CHANG%20CHIA-MING&rft.date=2021-01-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2021008502A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true